FRANKIE LEE POWELL
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NEWPORT NEWS, VA NPI 1780175554
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology VA ABBVIE INC. All categories
General Payments — all program years on this page
$4,566.43
- Category: General Payments
- Program years: PY2021–2024
- Record count: 175
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,046.74 across 50 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,046.74 | 50 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $267.47 | 10 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $135.07 | 7 |
| Daiichi Sankyo Inc. | $89.58 | 4 |
| PFIZER INC. | $68.83 | 4 |
| Genentech, Inc. | $68.74 | 1 |
| Alexion Pharmaceuticals, Inc. | $47.81 | 3 |
| Janssen Biotech, Inc. | $46.13 | 3 |
| EISAI INC. | $39.15 | 2 |
| Merck Sharp & Dohme Corporation | $38.79 | 2 |
| Astellas Pharma US Inc | $34.64 | 2 |
| Celgene Corporation | $30.04 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.45 | 1 |
| BeiGene USA, Inc. | $20.72 | 1 |
| GlaxoSmithKline, LLC. | $19.57 | 1 |
| Acerta Pharma LLC | $19.38 | 1 |
| Mirati Therapeutics, Inc. | $17.64 | 1 |
| Azurity Pharmaceuticals, Inc. | $17.37 | 1 |
| Genentech USA, Inc. | $17.09 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.25 | 1 |
| Incyte Corporation | $15.03 | 1 |
| Genmab U.S., Inc. | $14.99 | 1 |
By program year
Records — PY2024 (50)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.